UiPath (NYSE:PATH) Shares Down 9%

UiPath Inc. (NYSE:PATHGet Rating) fell 9% during mid-day trading on Friday . The company traded as low as $13.81 and last traded at $13.81. 398,260 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 8,089,977 shares. The stock had previously closed at $15.17.

Analyst Ratings Changes

A number of research firms have issued reports on PATH. Canaccord Genuity Group cut shares of UiPath from a “buy” rating to a “hold” rating and reduced their target price for the company from $25.00 to $15.00 in a research note on Wednesday, September 7th. Morgan Stanley cut shares of UiPath from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $32.00 to $15.00 in a research note on Wednesday, September 7th. Wells Fargo & Company reduced their target price on shares of UiPath from $30.00 to $22.00 and set an “overweight” rating for the company in a research note on Wednesday, September 7th. Oppenheimer reduced their target price on shares of UiPath from $35.00 to $23.00 and set a “buy” rating for the company in a research note on Thursday, June 2nd. Finally, Truist Financial dropped their price target on shares of UiPath from $45.00 to $25.00 and set a “buy” rating on the stock in a research report on Wednesday, September 7th. Seven research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, UiPath presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.97.

UiPath Stock Down 7.5 %

The stock’s 50-day moving average is $18.11 and its 200-day moving average is $20.03. The firm has a market cap of $7.64 billion, a P/E ratio of -17.54 and a beta of 0.11.

UiPath (NYSE:PATHGet Rating) last announced its earnings results on Tuesday, September 6th. The healthcare company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.09. The business had revenue of $242.22 million for the quarter, compared to analyst estimates of $230.68 million. UiPath had a negative net margin of 42.98% and a negative return on equity of 19.19%. UiPath’s revenue was up 23.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.17) earnings per share. As a group, analysts expect that UiPath Inc. will post -0.63 EPS for the current fiscal year.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 100,000 shares of the business’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $20.70, for a total value of $2,070,000.00. Following the sale, the chief financial officer now owns 1,387,266 shares of the company’s stock, valued at approximately $28,716,406.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Kimberly Hammonds sold 2,521 shares of the business’s stock in a transaction on Tuesday, June 21st. The shares were sold at an average price of $18.70, for a total value of $47,142.70. Following the sale, the director now owns 100,662 shares in the company, valued at approximately $1,882,379.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Ashim Gupta sold 100,000 shares of the business’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $20.70, for a total transaction of $2,070,000.00. Following the completion of the sale, the chief financial officer now owns 1,387,266 shares in the company, valued at approximately $28,716,406.20. The disclosure for this sale can be found here. Insiders have sold 165,321 shares of company stock valued at $3,177,103 in the last 90 days. 31.88% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UiPath

Institutional investors and hedge funds have recently made changes to their positions in the company. Prospera Financial Services Inc acquired a new stake in shares of UiPath in the 1st quarter valued at $27,000. SeaCrest Wealth Management LLC acquired a new stake in shares of UiPath in the 2nd quarter valued at $25,000. Banque Cantonale Vaudoise boosted its stake in shares of UiPath by 20,080.0% in the 2nd quarter. Banque Cantonale Vaudoise now owns 2,018 shares of the healthcare company’s stock valued at $37,000 after purchasing an additional 2,008 shares in the last quarter. AdvisorNet Financial Inc lifted its position in UiPath by 110.0% during the 1st quarter. AdvisorNet Financial Inc now owns 2,100 shares of the healthcare company’s stock worth $45,000 after buying an additional 1,100 shares in the last quarter. Finally, CWM LLC acquired a new position in UiPath during the 2nd quarter worth about $40,000. Institutional investors and hedge funds own 51.35% of the company’s stock.

UiPath Company Profile

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.